N@N

COMPUGEN LTD (NASDAQ:CGEN), Up By 5.49% ($0.25) From $4.550 After BUYINS.NET Report Predicted Strength After Earnings

^{Published on 2011-04-26 05:20:28 - WOPRAI}
 

April 26, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, April 25th 2011 stating that COMPUGEN LTD (NASDAQ:CGEN) was expected to be Up After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=cgen&id=162598

At the time this story was written, COMPUGEN LTD (NASDAQ:CGEN) is Up By 5.49% ($0.25) From $4.550 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

COMPUGEN LTD (NASDAQ:CGEN) - Compugen Ltd., an early stage drug and diagnostic discovery company, engages in the research, development, and commercialization of therapeutic peptides and proteins for cancer, cardiovascular, and immune-related diseases in the United States and Europe. The companys therapeutic peptide and protein related platforms include GPCR Therapeutic Peptide Ligands, Disease-Associated Conformation Blockers, Viral Peptides, and Splice Variant based Therapeutic Proteins; monoclonal antibody related platforms comprise Monoclonal Antibody Targets; and other therapeutic and diagnostic platforms consist of Nucleic-Acid Disease Markers, Protein Disease Markers, Nucleic-Acid Preclinical Toxicity Markers, Non-SNP Drug Response Markers, and New Indications. Its therapeutic peptide and protein product candidates comprise CGEN-855, a peptide agonist of the FPRL1 GPCR receptor; CGEN-856 and CGEN-857, which are MAS GPCR peptide agonists; CGEN-25007, an antagonist of the gp96 protein; CGEN-25008, a peptide antagonist; CGEN-25009, a peptide of the LGR7 receptor; CGEN-25017, a peptide antagonist; and CGEN-15001, a protein for the treatment of autoimmune disorders. The company also offers monoclonal antibody target product candidates, including CGEN-671, a drug for multiple epithelial tumors. In addition, it provides various therapeutic and diagnostic product candidates, such as CGEN-40001, a genetic biomarker for predisposition to type-2 diabetes; CGEN-226, a biomarker for early detection of preeclampsia; CGEN-327, a biomarker for ovarian cancer; and CGEN-50001, a small molecule drug for CNS related indications. Compugen has collaboration agreements with Pfizer and Bayer Schering Pharma AG. The company was founded in 1993 and is based in Tel Aviv, Israel.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. COMPUGEN LTD (NASDAQ:CGEN) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net